185 related articles for article (PubMed ID: 26900575)
1. Hypoxia inducible factor-1 alpha and multiple myeloma.
Bhaskar A; Tiwary BN
Int J Adv Res (Indore); 2016 Jan; 4(1):706-715. PubMed ID: 26900575
[TBL] [Abstract][Full Text] [Related]
2. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
Poon E; Harris AL; Ashcroft M
Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma.
Borsi E; Terragna C; Brioli A; Tacchetti P; Martello M; Cavo M
Transl Res; 2015 Jun; 165(6):641-50. PubMed ID: 25553605
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.
Storti P; Bolzoni M; Donofrio G; Airoldi I; Guasco D; Toscani D; Martella E; Lazzaretti M; Mancini C; Agnelli L; Patrene K; Maïga S; Franceschi V; Colla S; Anderson J; Neri A; Amiot M; Aversa F; Roodman GD; Giuliani N
Leukemia; 2013 Aug; 27(8):1697-706. PubMed ID: 23344526
[TBL] [Abstract][Full Text] [Related]
5. Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.
Asosingh K; De Raeve H; de Ridder M; Storme GA; Willems A; Van Riet I; Van Camp B; Vanderkerken K
Haematologica; 2005 Jun; 90(6):810-7. PubMed ID: 15951294
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia inducible factor pathways as targets for functional foods.
Losso JN; Bawadi HA
J Agric Food Chem; 2005 May; 53(10):3751-68. PubMed ID: 15884793
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma.
Choi SH; Kwon OJ; Park JY; Kim DY; Ahn SH; Kim SU; Ro SW; Kim KS; Park JH; Kim S; Yun CO; Han KH
Liver Int; 2014 Apr; 34(4):632-42. PubMed ID: 24321089
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible KDM3A addiction in multiple myeloma.
Ikeda S; Kitadate A; Abe F; Takahashi N; Tagawa H
Blood Adv; 2018 Feb; 2(4):323-334. PubMed ID: 29444873
[TBL] [Abstract][Full Text] [Related]
10. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.
Ria R; Catacchio I; Berardi S; De Luisi A; Caivano A; Piccoli C; Ruggieri V; Frassanito MA; Ribatti D; Nico B; Annese T; Ruggieri S; Guarini A; Minoia C; Ditonno P; Angelucci E; Derudas D; Moschetta M; Dammacco F; Vacca A
Clin Cancer Res; 2014 Feb; 20(4):847-58. PubMed ID: 24297864
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the adaption process of human microvascular endothelial cells (HMEC-1) to hypoxia: Redundant HIF-dependent regulation of macrophage migration inhibitory factor.
Hahne M; Schumann P; Mursell M; Strehl C; Hoff P; Buttgereit F; Gaber T
Microvasc Res; 2018 Mar; 116():34-44. PubMed ID: 28993199
[TBL] [Abstract][Full Text] [Related]
13. HIF-2α-ILK Is Involved in Mesenchymal Stromal Cell Angiogenesis in Multiple Myeloma Under Hypoxic Conditions.
Zhang X; Xu Y; Liu H; Zhao P; Chen Y; Yue Z; Zhang Z; Wang X
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764473. PubMed ID: 29656700
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.
Martin SK; Diamond P; Gronthos S; Peet DJ; Zannettino AC
Leukemia; 2011 Oct; 25(10):1533-42. PubMed ID: 21637285
[TBL] [Abstract][Full Text] [Related]
15. HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Borsi E; Perrone G; Terragna C; Martello M; Zamagni E; Tacchetti P; Pantani L; Brioli A; Dico AF; Zannetti BA; Rocchi S; Cavo M
Exp Cell Res; 2014 Nov; 328(2):444-55. PubMed ID: 25257607
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
17. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
19. Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression.
O'Donnell JL; Joyce MR; Shannon AM; Harmey J; Geraghty J; Bouchier-Hayes D
Cancer Treat Rev; 2006 Oct; 32(6):407-16. PubMed ID: 16889900
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
Xia T; Cheng H; Zhu Y
Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
